Entresto heart failure drug pill. Caplet of the combination drug sacubitril and valsarta, sold here under the brand name Entrasto, and developed and marketed by the Novartis pharmaceutical company. The drug sacubitril acts to inhibit the neprilysin enzyme, while the drug valsartan is an angiotensin receptor blocker (ARB). This combination drug was approved for use in 2015. | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Marazzi, Dr. P. |
Bildgröße: | 5568 px × 3712 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: |
|